Factors Affecting Use of PORT, Induction Chemotherapy, and Surgery to Improve Outcomes in NSCLC

Article Information

DOI 
http://dx.doi.org/10.1177/1559897715588278
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2015 SAGE Publications

Author Information

  1. Eleanor Mayfield
  1. Cécile Le Péchoux, MD
    1. Institut Gustave-Roussy, Villejuif, France
  2. Paul De Leyn, MD, PhD
    1. University Hospitals Leuven, Leuven, Belgium
View Full Text

Article usage

AbstractFullPDF
May 20151300
Jun 2015200
Aug 20151900
Sep 20157300
Oct 2015333
Nov 2015821
Total11854

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Factors Affecting Use of PORT, Induction Chemotherapy, and Surgery to Improve Outcomes in NSCLC
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

stage III non–small cell lung cancer
adjuvant chemotherapy
neoadjuvant chemotherapy
induction chemotherapy
postoperative radiation therapy
chemoradiation therapy
induction chemoradiation therapy
Oncology Clinical Trials
Adjuvant/Neoadjuvant Therapy